鑫富药业：收购报告书摘要

《鑫富药业：收购报告书摘要》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、浙江杭州鑫富药业股份有限公司收购报告书摘要上市公司名称：浙江杭州鑫富药业股份有限公司股票上市地点：深圳证券交易所股票简称：鑫富药业股票代码：002019收购人姓名：程先锋住所：安徽省肥西县紫蓬山旅游开发区通讯地址：合肥市经济技术开发区翡翠路399号财务顾问二〇一四年八月浙江杭州鑫富药业股份有限公司收购报告书摘要收购人声明一、收购人依据《中华人民共和国证券法》、《上市公司收购管理办法》、《公开发行证券的公司信息披露内容格式与准则第16号——上市公司收购报告书》及相关法律、法规编写本报告书；二、依据《中华

2、人民共和国证券法》、《上市公司收购管理办法》的规定，本报告书已全面披露收购人在浙江鑫富药业股份有限公司（以下简称“鑫富药业”）拥有的权益情况；截至本报告书签署之日，除本报告书披露的持股信息外，收购人没有通过任何其他方式在鑫富药业拥有权益；三、收购人签署本报告书已获得必要的授权和批准，其履行亦不违反收购人章程或内部规则中的任何条款，或与之相冲突；四、本次收购尚需在获得中国证券监督管理委员会核准同时豁免收购人要约收购义务后实施；五、本次收购是根据本报告书所载明的资料进行的。除收购人和所聘请的专业机构外，没

3、有委托或者授权任何其他机构或个人提供未在本报告书中列载的信息和对本报告书做出任何解释或者说明。1浙江杭州鑫富药业股份有限公司收购报告书摘要目录第一节释义··················································································································3第二节收购人介绍······················································

4、················································5一、收购人基本情况································································································5二、最近五年的任职情况·······················································································

5、·5三、最近五年内的处罚、仲裁及诉讼情况····························································6四、收购人所控制的核心企业和核心业务、关联企业及主营业务的情况说明6五、持有其他上市公司股份的情况········································································8第三节收购决定及收购目的······································

6、················································9一、本次收购的决定及履行的程序········································································9二、本次收购目的··································································································10三、是否拟在未来

7、12个月内继续增持上市公司股份或处置其已拥有权益的股份······························································································································10第四节收购方式···························································································

8、·············11一、收购人持有上市公司股份的情况··································································11二、本次交易合同的主要内容··············································································12三、本次交易基本方案···························